Trial Profile
A clinical study of chidamide with FLAG in the treatment of relapsed /refractory /first cycle induced non-remission acute myeloid leukemia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2018
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Fludarabine (Primary) ; Tucidinostat (Primary) ; Granulocyte colony-stimulating factors
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 27 Apr 2018 New trial record